1. ÓÀººÕòÔÆ¶¥¼¯ÍÅ-¿ÆÑ§¼Ò·¢ÏÖ¿ÉÒÔÔ¤²âBǰÌå¼±ÐÔÁܰÍϸ°û°×Ѫ²¡»¼ÕßÔ¤ºó½á¾ÖµÄ°Ð±ê

      2025-10-23 11:58:55

      ¿ÆÑ§¼Ò·¢Ã÷¿ÉÒԲ²âBǰÌå¼±ÐÔÁܰÍϸ°û°×Ѫ²¡»¼ÕßÔ¤ºóÖվֵİбê

      ÈÕÆÚ£º2022-04-26 À´Àú£º±¾Õ¾ ¹©¸å£º»¯Ñ§Ò©ÓëÒ½ÁÆÆ÷е´¦ ×÷ÕߣºÖÎÀíÔ± ÖÖ±ð£ºÒëÎÄ

      BǰÌå¼±ÐÔÁܰÍϸ°û°×Ѫ²¡£¨B-cell precursor acute lymphoblasticleukaemia, BCP-ALL£©Ô¼Õ¼¶ùͯ¼±ÐÔÁܰÍϸ°û°×Ѫ²¡µÄ80%£¬ÊÇ×î¶à¼ûµÄÀàÐÍ¡£¸ú×ÅÒ½ÖÎÊÖÍóµÄ³É³¤£¬BCP-ALLÔ¤ºóÓÐËù¸ÄÉÆ£¬µ«¸Ã²¡µÄ¸´·¢ÈÔÊÇÁÙ´²Ò½ÖÎÖÐÃæ¶ÔµÄ¾ÞÄêÒ¹ÌôÕ½£¬ÊÇÒÔѰÃٿɲ²âBCP-ALLÔ¤ºóÖվֵİбê¶ÔÓÚÁÙ´²Ò½Öξ߱¸Ö÷ÒªµÄÒýµ¼ÒâÒå¡£ ½üÈÕ£¬¡¶BLOOD¡·ÔÓÖ¾·¢±íÌâΪ¡°High BMP4 expression in low/intermediaterisÓÀººÕòÔÆ¶¥¼¯ÍÅ-k BCP-ALL identifies children with poor outcome¡±µÄÎÄÕ£¬·¢Ã÷Á˼ì²âѪҺÖйÇÐÎ̬·¢ÉúÂѰ×4£¨BMP4£©µÄ±í´ï³Ì¶È¿ÉÒԲ²â¶ùͯBCP-ALLµÄÔ¤ºóÖÕ¾Ö¡£ ¸ÃÑо¿¾­Óɹý³Ì115Àý¶ùͯBCP-ALL»¼ÕߵĻØÊ×ÐÔÐÐÁв½¶ÓÑо¿¼°236ÀýBCP-ALL»¼ÕßµÄ5ÄêËæ·ÃÑéÖ¤ÐÔÐÐÁв½¶ÓÑо¿£¬·¢Ã÷BMP4¸ß±í´ïÓëÔ¤ºó²»Á¼Öվָ߶ÈÏà¸É£¬ÊÇÒÔÓÚÒ½ÖÎÀú³ÌÖжÔÓÚBMP4µÄ±í´ï³Ì¶È¾ÙÐмà²âÓÐÒæÔÚÅж¨BCP-ALL»¼ÕßµÄÔ¤ºóÖÕ¾Ö¡£ ¸Ã°Ð±ê¾ßÓнÏÓŵÄÁÙ´²Õï¶Ï¼ÛÖµ£¬¿ÉÓÚ±ØÈ»Ë®Æ½ÉÏÇø±ð³öBCP-ALL»¼ÕßÖÐÔ¤ºó²»Á¼µÄÈËȺ£¬´Ó¶øÊµÏÖ¼°Ôç¸ÉÉæ¸ÉÓëÒÔ½úÉýBCP-ALL»¼ÕßµÄÒ½ÖÎЧ¹û¡£ ÂÛÎÄÁ´½Ó£ºhttps://doi.org/10.1182/blood.2021013506 ×¢£º´ËÑо¿½á¹ûÕª×Ô¡¶BLOOD¡·ÔÓÖ¾£¬ÎÄÕÂÄÚÈݲ»´ú±í±¾ÍøÕ¾²»Ñŵ㼰̬¶È£¬½ö¹©²Î¿¼¡£-ÓÀººÕòÔÆ¶¥¼¯ÍÅ-